Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Laurence P. Karper"'
Autor:
Katherine B. Martin Md, Laurence P. Karper, Siddhartha Maru, Maggie Driscoll, Elizabeth S. Kim
Publikováno v:
Case Reports in Psychiatry
Case Reports in Psychiatry, Vol 2021 (2021)
Case Reports in Psychiatry, Vol 2021 (2021)
Difficulties in communication often arise between individuals with autism spectrum disorder and their treating physicians because both sides struggle to find a common ground. The story of Darmok and Jalad at Tanagra from Star Trek: The Next Generatio
Autor:
Michael Kaufmann, Gary Millspaugh Mpa, Glenn Stern Ma, Laurence P. Karper, D. James Ezrow Msw, Mary Lynch Rn, Shirley Giansante Rn, Gail Stern Msn, Evett Vega Lsw
Publikováno v:
Journal of Dual Diagnosis. 4:142-157
Psychiatric symptoms and alcohol and drug use disorders are often diagnosed in individuals who frequent shelters and programs for homelessness. Services are often provided in a fragmented, uncoordinated manner. This study evaluates a care coordinatio
Autor:
Deepak Cyril D'Souza, E. Zuzarte, A. Bennett, Robert Sturwold, Kristen Morrissey, D. Abi-Saab, John H. Krystal, Roberto Gil, Laurence P. Karper, Jonathan A White, Karyn Cassello, Dennis S. Charney
Publikováno v:
Biological Psychiatry. 47:450-462
Background: The amino acid glycine, modulates neurotransmission via actions at GLY-A receptor and GLY-B receptor. The latter are coagonist sites associated with N-Methyl- d -Aspartate (NMDA) glutamate receptors. The central bioavailability of periphe
Autor:
John H. Krystal, D. Cyril D'Souza, Laurence P. Karper, Alexandre Bennett, Anissa Abi-Dargham, Danielle Abi-Saab, Karyn Cassello, M. B. Bowers Jr., Sally Vegso, George R. Heninger, Dennis S. Charney, M. B. Bowers
Publikováno v:
Psychopharmacology. 145:193-204
Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist with prominent psychoactive effects in humans. This study evaluated whether the oral administration of haloperidol 5 mg would block the effects of an intravenous ketamine infusion (bolus
Autor:
Dennis S. Charney, J.H. Krystal, Laurence P. Karper, Christian Grillon, G.K. Freeman, C A Morgan rd
Publikováno v:
The Journal of Neuropsychiatry and Clinical Neurosciences. 8:60-66
Impaired sensory gating and increased distractibility are key information-processing deficits in schizophrenia. This study evaluated the hypothesis that distractibility is related to reduced sensory gating. Performance on vigilance and distractibilit
Publikováno v:
Journal of Offender Rehabilitation. 21:203-222
The psychopharmacologic treatment of aggression is a critical component of the treatment of psychiatric patients. This review focuses on the use of antipsychotics, benzodiazepines, beta- 6 lockers, and lithium in the treatment of aggression in adult
Autor:
Dennis S. Charney, Laurence P. Karper
Publikováno v:
Current Opinion in Psychiatry. 7:140-143
Publikováno v:
The Journal of Neuropsychiatry and Clinical Neurosciences. 4:454-457
Two patients with prolonged postictal encephalopathy lasting 63 and 72 hours, respectively, following seizures with clozapine are reported. Clozapine alters the EEG in a majority of patients treated, with seizure frequency as high as 5-10% in doses a
Autor:
Louise M. Brenner, Joseph Erdos, Edward Perry, D. Cyril D’Souza, Joseph L. Goulet, Paul H. Lysaker, John H. Krystal, Morris D. Bell, Laurence P. Karper, R. Andrew Sewell, John Seibyl
Publikováno v:
Schizophrenia research. 124(1-3)
Background Nonlocalizing neurologic deficits detectable by clinical evaluation–“soft signs”–are a robust finding in patients diagnosed with schizophrenia, but their conceptual and neuroanatomical correlates remain unclear. The purpose of this
Autor:
Angelina Genovese, Edward Perry, Joyce A. Cramer, Laurence P. Karper, Elizabeth O’Donnell, Ismene L. Petrakis, Hyun Sang Cho, John H. Krystal, D. Cyril D’Souza
Publikováno v:
Psychopharmacology. 192(2)
A growing number of investigators are studying ketamine effects in healthy human subjects, but concerns remain about its safety as a research tool. Therefore, it is timely to revisit the safety of subanesthetic doses of ketamine in experimental psych